Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: A study vs AIA without polyps, mild topic asthma, and normal controls

European Annals of Allergy and Clinical Immunology

Volumn 38, Issue 1, 2006, Pages 20-23

  Micheletto, C ^a   Visconti, M ^a   Tognella, S ^a   Facchini, F M ^a   Dal Negro, R W ^a  

^a Bussolengo Hospital   (Italy)

Author keywords

Aspirin induces asthma; LTE4; Nasal polyposis

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CREATININE; LEUKOTRIENE E4; METHACHOLINE; PEPTIDOLEUKOTRIENE; SALBUTAMOL;

ADULT; ALLERGIC ASTHMA; ARTICLE; ASPIRIN INDUCED ASTHMA; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATORY CELL; NOSE POLYP; PATIENT MONITORING; PRICK TEST; RESPIRATORY FUNCTION; RHINITIS; URINE LEVEL;

ADULT; ASPIRIN; ASTHMA; BIOLOGICAL MARKERS; BRONCHIAL PROVOCATION TESTS; HUMANS; LEUKOTRIENE E4; MIDDLE AGED; NASAL POLYPS; RHINITIS;

EID: 32444436086     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Samter M, Beers RF. Intolerance to Aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med 1968; 68: 975-83.
2. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relatioship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1975; 1: 67-9.
3. Lee TH. Mechanisms of aspirin sensitivity. Am Rev Respir Dis 1992; 145: S34-6.
4. Sanak M, Pierzchalska M, Bazan-Socha S, Szczeklik A. Enhanced expression of the leukotriene C4 synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol. 2000, 23, pp 290-6.
5. Kawagishi Y, Mita H, Taniguchi M, Maruyama M, Oosaki R, Higashi N, Kashii T, Kobayashi M, Akiyama K. Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. J Allergy Clin Immunol 2002; 109: 936-42;
6. Christie PE, Tagari P, Ford-Hutchinson AW, Charlesson S, Chee P, Arm JP, Lee TH. Urinary Leucotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991; 143: 1025-29.
7. Kumlin M, Hahlén B, Bjorck T, Zetterstrom O, Granstrom E, Dahlen SE. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to provocations with allergen, aspirin, leukotriene D4 and histamine in asthmatics. A Rev Resp Dis 1992; 146: 96-103.
8. Nizankoswska E, Bestynska-Krypel A, Cmiel A, Szczeklik A. Orala and bronchial provocation tests with aspirin for diagnosis os aspirin-induced asthma. Eur Resp J 2000; 15: 863-869;
9. C Micheletto, RW Dal Negro, M Visconti,. Changes in urinary LTE4 and acustic rhinomanometry following nasal challenge with ASA in ASA-tolerant and ASA-intolerant asthmatics. Eur Resp J 2002; 20, suppl. 38, P1947.
10. Lynch KR, O'Neil GP, Liu Q, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999; 399: 789-93.
11. Figueroa DJ, Breyer RM, Defoe SK, et al. Expression of the cysteinyl leukotriene1 receptor in normal human lung and periferal blood leukocytes. Am Rev Respir Crit Care Med 2001; 163: 226-33.
12. Nicosia S, Capra V, Rovati GE. Leukotrienes as mediator of asthma. Pulm Pharmacol Ther 2001; 14: 3-19.
13. Obase Y, Shimoda T, Tomari S, Mitsuta K, Kawano T, Matsuse H, Kohno S. Effects of Pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatics patients. Chest 2002; 121: 143-150.
14. Lee DKC, Haggart K, Robb FM, Lipworth BJ. Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma. Eur Resp J 2004; 24: 226-30.
15. C Micheletto, S Tognella, M Visconti, C Pomari, F Trevisan, RW Dal Negro. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo. Allergy 2004; 59: 289-24.
16. Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expresson on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002; 347: 1493-9
17. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003; 111: 913-21;
18. Szczeklik A, Nizankowska E, Duplaga M, on behalf of the AIANE investigators: Natural history of aspirin-induced asthma. Eur Resp J 2000; 16: 432-6;
19. Casadevall J, Ventura P-J, Mullol J, Picado C. Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry. Thorax 2000; 55: 921-924
20. Lai V, Corey J. The use of acoustic rhinometry to quantitatively assess changes after intranasal allergen challenge. Am J Rhinology 1994; 8: 171-173.
21. Kumlin M, Stensvad F, Larsson L, Dahlen B, Dahlen SE. Validation and application of a new simple strategy of measurements of urinary LTE4 in humans. Clin Exp Allergy 1995; 25: 467-479.
22. Picado C. Aspirin intolerance and nasal polyposis. Curr Allergy Asthma Rep. 2002; 2 (6): 488-93.
23. Higashi N, Taniguchi M, Mita H, Ishii T, Akiyama K. Nasal blockage and urinary leukotriene E4 concentration in patients with seasonal allergic rhinitis. Allergy 2003; 58 (6): 476-80.